Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

camptothecin peptide conjugates

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Drug-Linker Conjugates for ADC (1) ADC Payload (3) Drug Intermediate (1) Topoisomerase (3)
By Research Areas:	Cancer (5)
Click Chemistry:	DBCO (1)

Inhibitors & Agonists

Peptides

Click Chemistry

Targets Recommended:

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-160807

DBM-GGFG-NH-O-CO-Exatecan	Drug-Linker Conjugates for ADC	Cancer
DBM-GGFG-NH-O-CO-Exatecan (Example 4, Compound 14) is a conjugate of an ADC drug toxin molecule and a linker. DBM-GGFG-NH-O-CO-Exatecan is a complete antibody-drug conjugate intermediate that integrates a potent camptothecin-based toxin, a cleavable peptide linker (GGFG), and a reactive terminus that can directly conjugate to antibodies .

HY-132164

Gly-7-MAD-MDCPT	ADC Payload Topoisomerase	Cancer
Gly-7-MAD-MDCPT (compound 4b) is an anticancer agent. Gly-7-MAD-MDCPT is a Camptothecin (HY-16560) compound, it shows cytotoxicity to various cancer cells with IC₅₀ values of 10-1000 nM .

HY-132164B

Gly-7-MAD-MDCPT TFA	ADC Payload Topoisomerase	Cancer
Gly-7-MAD-MDCPT (Compound 4b) TFA is an anticancer agent. Gly-7-MAD-MDCPT TFA is a Camptothecin (HY-16560) compound, which shows cytotoxicity to various cancer cells with IC₅₀ values of 10-1000 nM .

HY-132164A

Gly-7-MAD-MDCPT hydrochloride	ADC Payload Topoisomerase	Cancer
Gly-7-MAD-MDCPT (Compound 4b) hydrochloride is an anticancer agent. Gly-7-MAD-MDCPT hydrochloride is a Camptothecin (HY-16560) compound, which shows cytotoxicity to various cancer cells with IC₅₀ values of 10-1000 nM .

HY-P11755

DBCO-P-LPK	Drug Intermediate	Cancer
DBCO-P-LPK is a DBCO-modified colorectal cancer-specific binding peptide that serves as a key intermediate for targeted anticancer conjugates. DBCO-P-LPK enables the synthesis of the P-LPK-Camptothecin (HY-16560) conjugate. DBCO-P-LPK is applicable to the research of colorectal cancer .

Cat. No.	Product Name	Target	Research Area

HY-P11755

DBCO-P-LPK	Drug Intermediate	Cancer
DBCO-P-LPK is a DBCO-modified colorectal cancer-specific binding peptide that serves as a key intermediate for targeted anticancer conjugates. DBCO-P-LPK enables the synthesis of the P-LPK-Camptothecin (HY-16560) conjugate. DBCO-P-LPK is applicable to the research of colorectal cancer .

Cat. No.	Product Name		Classification

HY-P11755

DBCO-P-LPK		DBCO
DBCO-P-LPK is a DBCO-modified colorectal cancer-specific binding peptide that serves as a key intermediate for targeted anticancer conjugates. DBCO-P-LPK enables the synthesis of the P-LPK-Camptothecin (HY-16560) conjugate. DBCO-P-LPK is applicable to the research of colorectal cancer .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

MedchemExpress Validation 03

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred

MedchemExpress Validation 04

MedchemExpress Validation

We use cookies

MedChemExpress values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Privacy and Cookie Policy

Name
Email *

	Sorry, but the email address you supplied was invalid.